N

New York Eye and Ear Infirmary of Mount Sinai | Mount Sinai Ophthalmology

Research site

(Unclaimed)

Location

310 East 14th Street, South Building Room 601, New York, New York, United States of America

Site insights

Top conditions

Top treatments

OTO-104

5-Aminolevulinic Acid

Survodutide

RPh201

FWY003

Presendin

Latanoprost

BI 764524

BI 836880

Bimatoprost

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 25 total trials

A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

To characterize the dose response relationship of FWY003 in participants with geographic atrophy (GA) secondary to age-related macular degeneration (...

Enrolling

Geographic Atrophy Secondary to Age-related Macular Degeneration

Drug: FWY003

Drug: Placebo

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

This study is open to adults who are at least 18 years old and have:* A confirmed liver disease called non-alcoholic steatohepatitis (NASH) or* A con...

Enrolling

Metabolic Dysfunction Associated Steatohepatitis

Combination Product: Survodutide

Combination Product: Placebo matching survodutide

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

This study is open to adults who are at least 18 years old living with obesity and have:* a confirmed liver disease called non-alcoholic steatohepati...

Enrolling

Metabolic Dysfunction Associated Steatohepatitis (MASH)

Liver Fibrosis

Combination Product: Placebo

Combination Product: Survodutide